BCR-ABL:慢性髓性白血病背后的分子大脑
Tara Shammas1, Malalage N Peiris2, April N Meyer1
1Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093-0367, USA.
Cytokine & growth factor reviews
|May 13, 2025
概括
费城染色体通过BCR-ABL融合基因引起慢性髓性白血病 (CML). 研究重点是准这种基因,克服对氨酸激酶抑制剂 (TKI) 的耐药性,以改善CML治疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性骨髓性白血病 (CML) 是一种由费城染色体 (Ph) 所表现的造血性癌症,是t(9;22) 转位的结果.
- Ph染色体导致BCR-ABL融合基因,产生一个构成性活跃的氨酸激酶,驱动癌细胞的增殖和存活.
- CML约占所有新的白血病诊断的15%,使其成为一个重要的研究领域.
研究的目的:
- 审查CML中BCR-ABL融合的历史发现和病因.
- 讨论了解BCR-ABL监管机制的最新进展.
- 探索针对BCR-ABL的新兴治疗策略,包括克服TKI耐药性.
主要方法:
- 文献综述侧重于CML的遗传基础.
- 通过BCR-ABL融合蛋白调节的信号通路的分析.
- 检查CML治疗的当前和新型治疗方法.
主要成果:
- BCR-ABL融合蛋白激活关键信号通路 (Ras/MAPK,PI3K/AKT,JAK/STAT,NF-kappaB),促进细胞不受控制的生长.
- 氨酸激酶抑制剂 (TKIs) 是标准的治疗方法,但治疗耐药性是一个越来越大的挑战.
- 发现BCR-ABL对于推进癌症的精准医学至关重要.
结论:
- BCR-ABL融合基因是CML的核心驱动因素,为治疗提供了一个特定的标.
- 持续的研究对于开发新型疗法来打击TKI耐药性和改善CML患者的治疗结果至关重要.
- 了解BCR-ABL范式对癌症遗传学和向治疗的发展产生了重大影响.
相关概念视频
Diversity of Antigen Receptors
393
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
393
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Bone Marrow Sampling and Transplants
265
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
265
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


